Tirzepatide and semaglutide had a 64% and 34% probability of being cost-effective at a $100,000 per QALY threshold, respectively.

Topline data were announced from a phase 3 trial evaluating garetosmab in adults with fibrodysplasia ossificans progressiva.

Anifrolumab, a type I interferon receptor antagonist, is currently approved under the brand name Saphnelo for IV administration in the treatment of moderate to severe SLE.

Willingness to prescribe estrogen therapy for patients with a history of gynecologic cancer varied by specialty, experience, and sex.

The semaglutide discontinuation rate at 1 year was found to be 52%, and age, sex, and socioeconomic status were associated with it.

Parent-focused early childhood obesity prevention interventions were not significantly associated with differences in offspring BMI.

Delaying MTX initiation by 4 weeks after PCV13 vaccination significantly improved humoral responses in patients with RA, without compromising disease control.

Which of the statements about the American College of Rheumatology guidance statement for diagnosing and managing VEXAS are correct?

The prevalence of T2D among a cohort of patients in Italy with SSc was lower than national estimates and associated with distinct vascular and cardiopulmonary features.

Active LN and the presence of U1-RNP antibodies were linked to low BMD and osteoporosis among patients with SLE.

Patients with rheumatoid arthritis (RA) undergo cervical cancer screening less often than those without RA, but screening rates for other cancers are not significantly delayed, according to study ...

Topline data were announced from a phase 3 trial evaluating efzofitimod in patients with pulmonary sarcoidosis.